KPRX - KIORA PHARMACEUTICALS INC
1.98
-0.050 -2.525%
Share volume: 45,313
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$2.03
-0.05
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-08-2024 | 03-25-2025 | 05-09-2025 | 08-08-2025 | 11-07-2025 | |
| Assets | ||||||||
| Total Assets | 42.440 M | 40.814 M | 38.509 M | 36.484 M | 34.020 M | 31.946 M | 29.863 M | |
| Current Assets | 33.482 M | 31.831 M | 31.653 M | 29.706 M | 27.107 M | 24.737 M | 22.694 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.455 M | |
| Short Term Investments | 0.000 | 21.243 M | 23.398 M | 23.000 M | 20.335 M | 19.638 M | 13.867 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 31.276 M | 6.575 M | 5.637 M | 3.792 M | 3.771 M | 1.028 M | 5.509 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 12.918 K | 63.487 K | 62.609 K | 5.232 K | 4.984 K | 106.843 K | 101.807 K | |
| Other Assets | 8.945 M | 8.920 M | 6.794 M | 6.773 M | 6.908 M | 7.102 M | 7.068 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 42.440 M | 40.814 M | 38.509 M | 36.484 M | 34.020 M | 31.946 M | 29.863 M | |
| Total liabilities | 7.536 M | 7.713 M | 8.479 M | 10.725 M | 10.319 M | 9.818 M | 7.453 M | |
| Total current liabilities | 1.593 M | 1.656 M | 3.528 M | 6.009 M | 5.275 M | 3.186 M | 2.580 M | |
| Accounts Payable | 323.062 K | 268.638 K | 660.415 K | 415.590 K | 942.492 K | 282.537 K | 241.471 K | |
| Other liabilities | 5.163 M | 5.277 M | 4.172 M | 4.225 M | 4.554 M | 4.892 M | 3.132 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 5.163 M | 5.277 M | 4.172 M | 4.225 M | 4.554 M | 4.892 M | 3.132 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 34.904 M | 33.102 M | 30.030 M | 25.760 M | 23.700 M | 22.127 M | 22.411 M | |
| Common stock | 168.692 M | 169.093 M | 169.264 M | 169.424 M | 169.573 M | 170.101 M | 170.355 M | |
| Retained earnings | -133.524 M | -135.745 M | -139.159 M | -143.382 M | -145.575 M | -147.728 M | -147.701 M |